NSE: CONCORDBIO | BSE: 543960

Expensive Performer

1748.50 81.60 (4.90%)

1.5M NSE+BSE Volume

NSE 30 May, 2025 3:59 PM (IST)

18,292.1

Market Cap

Market Runner Up

0.7

Beta 1Year

Very Low volatility

Estimates Beat

Concord Biotech's Q4 profit and revenue beat Forecaster estimates by 22.9% and 14.9%, respectively See details

Board Meetings - Concord Biotech Ltd.

The latest board meeting for Concord Biotech Ltd. took place on 29 May 2025, for the purpose of Audited Results & Final Dividend

Ex-date	Purpose	Notes
29 May 2025	Audited Results & Final Dividend	-
13 Feb 2025	Quarterly Results	-
11 Nov 2024	Quarterly Results	-
09 Aug 2024	Quarterly Results	-
23 May 2024	Audited Results & Dividend	-
08 Feb 2024	Quarterly Results	-
08 Nov 2023	Quarterly Results	-